Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke in cancer patients.

Teri Nguyen1, Lisa M DeAngelis

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Current Neurology and Neuroscience Reports
|April 26, 2006
PubMed
Summary

Cancer patients face a higher stroke risk due to their malignancy. Understanding unique cancer-related stroke mechanisms is crucial for effective secondary prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification and Management of Ischemic Stroke in Patients With Active Cancer: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma.

Neuro-oncology·2026
Same author

Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.

Neuro-oncology·2025
Same author

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.

Acta neuropathologica·2025
Same author

Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.

Neuro-oncology·2025
Same author

Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.

Neuro-oncology·2025

Area of Science:

  • Oncology
  • Neurology
  • Vascular Medicine

Background:

  • Cancer patients exhibit elevated risks for cerebrovascular events.
  • Malignancies can directly or indirectly precipitate stroke.
  • Certain tumors are associated with a high likelihood of cerebrovascular complications.

Purpose of the Study:

  • To highlight stroke risks in cancer patients.
  • To discuss cancer-specific stroke mechanisms.
  • To emphasize tailored secondary prevention strategies.

Main Methods:

  • Review of existing literature on cancer and stroke.
  • Analysis of direct and indirect effects of malignancy on cerebrovascular health.
  • Identification of specific stroke mechanisms in cancer patients.

Main Results:

  • Cancer-related stroke mechanisms include tumor compression/occlusion of cerebral vessels.
  • Coagulopathy in cancer predisposes to hemorrhage and thrombosis.
  • Treatment-related atherosclerosis is a significant factor.

Conclusions:

  • Evaluating cancer patients requires special consideration of unique stroke mechanisms.
  • Secondary stroke prevention must integrate patient prognosis and care goals.
  • Personalized treatment approaches are essential for managing cerebrovascular risks in oncology.

Related Experiment Videos